✦ LIBER ✦

Regulatory considerations on the role of general pharmacology studies in the development of therapeutic agents

✍ Scribed by Anthony G. Proakis

Publisher: John Wiley and Sons
Year: 1994
Tongue: English
Weight: 385 KB
Volume: 32
Category: Article
ISSN: 0272-4391
DOI: 10.1002/ddr.430320407

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Potential Opportunity in the Development

Potential Opportunity in the Development of New Therapeutic Agents Based on Endogenous and Exogenous Inhibitors of the Proprotein Convertases

✍ Yannick Bontemps; Nathalie Scamuffa; Fabien Calvo; Abdel-Majid Khatib 📂 Article 📅 2007 🏛 John Wiley and Sons ⚖ 11 KB

New evidence for the role of interferon

New evidence for the role of interferon regulatory factor 5 in the development of systemic lupus erythematosus: Comment on the article by Tada et al

✍ Hai-Feng Pan; Rui-Xue Leng; Dong-Qing Ye 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 33 KB 👁 2 views

On a general class of conditional tests

On a general class of conditional tests for family-based association studies in genetics: the asymptotic distribution, the conditional power, and optimality considerations

✍ Christoph Lange; Nan M. Laird 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 208 KB 👁 1 views

## Abstract Family‐based association tests (FBATs) provide simple and powerful tests to detect association between a genetic marker and a disease‐susceptibility locus, manifest in subjects by a phenotype or disease trait. Here we propose a new class of conditional tests for family‐based association

Selection of study population in the dev

Selection of study population in the development of rheumatic disease criteria: comment on the article by the american college of rheumatology diagnostic and therapeutic criteria committee

✍ Alan J. Silman; Deborah P. M. Symmons 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 131 KB 👁 2 views